PFE | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

Rebecca Urena03/29/202203/29/2022

17364

The Food and Drug Administration has authorized a fourth Covid vaccine dose for both Pfizer (NYSE: PFE) and Moderna (NASDAQ: PFE), for people 50 years of age and older....

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Rebecca Urena03/22/202203/22/2022

18305

Pfizer (NYSE: PFE) is set to provide up to 4 million doses of its Covid-19 pill, Paxlovid, to low and middle-income countries amid an agreement with Unicef, the global...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

financial buzz12/23/202106/22/2022

5223

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Gerald Commissiong, CEO of Todos Medical, is scheduled to appear on Yahoo Finance...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Rebecca Urena12/22/202106/14/2022

7275

Pfizer’s (NYSE: PFE) oral Covid treatment, Paxlovid, was granted emergency authorization by the Food and Drug Administration on Wednesday. This is the first approved antiviral Covid-19 pill for infected...

Healthcare Investing News Market News Pharmaceutical Science Technology The Market Buzz

Pfizer Reported Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate

Bryan Shin12/15/202106/09/2022

5315

Pfizer Inc. (NYSE: PFE) stock continues to climb as the threat from new variants of COVID 19 endures. PFE shares are up another 3%, currently trading near the all-time...

Tag: PFE

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Breaking News: Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Pfizer Reported Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate

ABOUT US

Tweets